ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
34 hedge funds and large institutions have $32.3M invested in Zynerba Pharmaceuticals, Inc in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
23% more capital invested
Capital invested by funds: $26.3M → $32.3M (+$6.06M)
Holders
34
Holding in Top 10
–
Calls
$3.4M
Puts
$28K
Top Buyers
| 1 | +$1.11M | |
| 2 | +$919K | |
| 3 | +$777K | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$725K |
| 5 |
RIL
Rothschild Investment LLC
Chicago,
Illinois
|
+$365K |
Top Sellers
| 1 | -$2.3M | |
| 2 | -$417K | |
| 3 | -$279K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$218K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$95.4K |